Recovery From Anesthesia After Robotic Assisted Radical Cystectomy

Regina Elena Cancer Institute50 enrolled

Overview

Robot-assisted radical cystectomy (RARC) requires specific surgical conditions: steep Trendelenburg position, prolonged pneumoperitoneum, effective neuromuscular block until the final stages of surgery. The aim of this study was to evaluate the quality of awakening in two groups of patients undergoing different combinations of curarization/reversal.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Anesthesiology Management

Interventions

Sugammadex Injectable ProductDRUG

Patients receive sugammadex at the end of the surgery

Neostigmine, AtropineDRUG

Patients receive neostigmine+atropine at the end of the surgery

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ASA (american society of anesthesiologists) score ≤ III * Patients underwent robotic assisted cystectomy Exclusion Criteria: * Cerebrovascular disease * BMI (body mass index) ≥ 30

Locations (2)

Ester Forastiere

Rome, RM, Italy

RECRUITING

Regina Elena Cancer Institute

Rome, RM, Italy

RECRUITING

Outcomes

Primary Outcomes

Time to discharge from recovery room

Time between reversal administration and discharge from the recovery room

Time frame: Up to 240 Minutes After recovery

Central Contacts

Ester Forastiere, Chief

CONTACT

+39 06 52662449 ester.forastiere@ifo.gov.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.